Key result
Complete resection of a 12.5-kg retroperitoneal liposarcoma following neoadjuvant chemotherapy yields no 3-month recurrence.
Why the study?
Primary retroperitoneal liposarcoma often causes diagnostic and therapeutic challenges due to delayed presentation and anatomical location, with complete resection remaining the mainstay of treatment despite high recurrence rates.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
Complete surgical resection combined with neoadjuvant and adjuvant chemotherapy for a massive retroperitoneal liposarcoma resulted in no recurrence at 3 months.
Introduction: Primary retroperitoneal liposarcoma is a rare variety of tumors accounting for 0.07%–0.2% of all malignancies. This type of sarcoma often causes diagnostic and therapeutic challenges due to its delayed presentation and anatomical location. Though there are some oncological measures like chemotherapy and radiotherapy still persist, complete surgical resection is the mainstay of treatment. However, the recurrence rate is very high in the case of retroperitoneal sarcomas. Case presentation: A 34-year-old male patient presented to our surgery department with abdominal distension, a lumpy feeling in his upper abdomen, and a significant weight loss over the past 3 months. On examination, there was a large intraabdominal mass measuring about 20 × 15 cm in the epigastric, left hypochondriac, umbilical, and left lumber region, which was partially mobile, partly hard, and partly cystic in consistency; the surface was smooth, and the margin was regular. After diagnostic and radiological workup, our primary suspicion was, it might be a case of retroperitoneal liposarcoma. Computed tomography (CT) guided fine needle aspiration tomography (FNAC) reveals, it was a spindle cell sarcoma. However, after six cycles neoadjuvant chemotherapy, resection was performed. Complete resection (R0) was done with extraction of a soft tissue mass of 12.5 kg, followed by adjuvant chemotherapy for three cycles. No recurrence is found after 3-month follow-up. Conclusion: Though retroperitoneal sarcoma may challenge the surgeon’s skill, complete marginal clearance along with oncological consultation may delay the recurrence and improve the quality of life of the patients. However, careful and long-term follow-up is required to detect early recurrence and increase the life expectancy of the patients.
No takes yet. Share an insight, caveat, or question.
Saha et al. (2025) conducted a case report in Retroperitoneal dedifferentiated liposarcoma (n=1). Neoadjuvant chemotherapy, complete surgical resection, and adjuvant chemotherapy was evaluated on Recurrence. Complete surgical resection (R0) of a 12.5 kg retroperitoneal liposarcoma following neoadjuvant chemotherapy resulted in no recurrence at 3-month follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: